Active Biotech AB (ACTI) — Financial Flexibility Index
Active Biotech AB (ACTI) has a Financial Flexibility Index of -0.73x as of March 2026. Free cash flow of Skr-8.00 Million (operating CF Skr-8.00 Million minus capex Skr0.00) represents -1% of total liabilities (Skr11.00 Million). Check how aggressively does Active Biotech AB reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Active Biotech AB Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Active Biotech AB across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Active Biotech AB.
Annual Financial Flexibility Index for Active Biotech AB (2002–2025)
Year-by-year free cash flow to debt coverage for Active Biotech AB. Explore ACTI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-32.40 Million | Skr14.60 Million | ▲ +100.0% |
| 2024 | -3.63x | Skr-40.40 Million | Skr-40.40 Million | Skr11.13 Million | ▼ -6.2% |
| 2023 | -3.42x | Skr-45.74 Million | Skr-45.74 Million | Skr13.38 Million | ▼ -3.3% |
| 2022 | -3.31x | Skr-54.60 Million | Skr-54.85 Million | Skr16.49 Million | ▲ +27.4% |
| 2021 | -4.56x | Skr-46.17 Million | Skr-46.17 Million | Skr10.13 Million | ▼ -42.1% |
| 2020 | -3.21x | Skr-32.22 Million | Skr-32.22 Million | Skr10.04 Million | ▼ -18.0% |
| 2019 | -2.72x | Skr-35.81 Million | Skr-35.81 Million | Skr13.17 Million | ▼ -1335.0% |
| 2018 | -0.19x | Skr-40.65 Million | Skr-40.65 Million | Skr214.52 Million | ▲ +7.7% |
| 2017 | -0.21x | Skr-46.45 Million | Skr-46.45 Million | Skr226.14 Million | ▲ +35.3% |
| 2016 | -0.32x | Skr-73.16 Million | Skr-73.16 Million | Skr230.32 Million | ▲ +60.8% |
| 2015 | -0.81x | Skr-217.89 Million | Skr-217.89 Million | Skr268.84 Million | ▲ +3.1% |
| 2014 | -0.84x | Skr-265.19 Million | Skr-267.09 Million | Skr317.21 Million | ▼ -196.4% |
| 2013 | -0.28x | Skr-102.20 Million | Skr-102.25 Million | Skr362.40 Million | ▲ +58.1% |
| 2012 | -0.67x | Skr-240.38 Million | Skr-240.40 Million | Skr356.82 Million | ▼ -417.1% |
| 2011 | -0.13x | Skr-46.44 Million | Skr-46.97 Million | Skr356.53 Million | ▲ +78.7% |
| 2010 | -0.61x | Skr-196.23 Million | Skr-196.32 Million | Skr321.34 Million | ▲ +15.8% |
| 2009 | -0.73x | Skr-224.70 Million | Skr-224.77 Million | Skr309.86 Million | ▼ -43.2% |
| 2008 | -0.51x | Skr-156.61 Million | Skr-159.46 Million | Skr309.34 Million | ▲ +18.6% |
| 2007 | -0.62x | Skr-186.61 Million | Skr-186.70 Million | Skr299.97 Million | ▼ -149.9% |
| 2006 | -0.25x | Skr-100.10 Million | Skr-100.13 Million | Skr402.04 Million | ▲ +48.0% |
| 2005 | -0.48x | Skr-187.28 Million | Skr-192.51 Million | Skr391.05 Million | ▲ +51.8% |
| 2004 | -0.99x | Skr-149.58 Million | Skr-149.65 Million | Skr150.59 Million | ▲ +80.8% |
| 2003 | -5.17x | Skr-288.76 Million | Skr-288.83 Million | Skr55.82 Million | ▼ -54.9% |
| 2002 | -3.34x | Skr-291.31 Million | Skr-291.71 Million | Skr87.24 Million | — |